Bruce & Co., Inc. Abbott Laboratories Transaction History

Bruce & Co., Inc.

$205 Million
Q2 2024

A detailed history of Bruce & Co., Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Bruce & Co., Inc. holds 152,300 shares of ABT stock, worth $17.6 Million. This represents 7.73% of its overall portfolio holdings.

Number of Shares

152,300

Previous 150,000 1.53%

Holding current value

$17.6 Million

Previous $17 Million 7.18%

% of portfolio

7.73%

Previous 8.4%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $231,679 - $258,612	2,300 Added 1.53%	152,300 $15.8 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $901,900 - $1.1 Million	-10,000 Reduced 6.25%	150,000 $16.5 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $653,711 - $784,344	-6,843 Reduced 4.1%	160,000 $15.5 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $73,323 - $86,305	-757 Reduced 0.45%	166,843 $16.9 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $1.14 Million - $1.39 Million	-10,000 Reduced 5.63%	167,600 $19.8 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $8.98 Million - $9.94 Million	-77,000 Reduced 30.24%	177,600 $21 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $2.34 Million - $2.73 Million	-32,115 Reduced 11.2%	254,600 $21.4 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $2.3 Million - $2.54 Million	40,000 Added 16.21%	286,715 $17.5 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $889,066 - $1.01 Million	15,800 Added 6.84%	246,715 $14.8 Million
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $11.1 Million - $12.4 Million	230,915	230,915 $12.3 Million

Others Institutions Holding ABT

# of Institutions

3,191

Shares Held

1.32B

Call Options Held

8.13M

Put Options Held

7.11M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.

Account